Cytokinetics (CYTK) News Today $49.16 -0.60 (-1.21%) As of 12:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CYTK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Cytokinetics announces private placement of $550M of convertible senior notesSeptember 17 at 2:03 AM | msn.comCytokinetics Announces Pricing of Upsized $650.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2027 Convertible NotesSeptember 16 at 11:45 PM | globenewswire.comCytokinetics stock falls after announcing $550 million convertible notes offeringSeptember 16 at 6:25 PM | ca.investing.comInsider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells 5,000 Shares of StockSeptember 16 at 5:21 PM | marketbeat.comCytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior NotesSeptember 16 at 4:02 PM | globenewswire.comCytokinetics, Incorporated $CYTK Shares Bought by E. Ohman J or Asset Management ABSeptember 16 at 5:22 AM | marketbeat.comIntech Investment Management LLC Purchases 16,988 Shares of Cytokinetics, Incorporated $CYTKSeptember 16 at 3:20 AM | marketbeat.com7,663 Shares in Cytokinetics, Incorporated $CYTK Acquired by United Services Automobile AssociationSeptember 15 at 3:51 AM | marketbeat.comWoodline Partners LP Boosts Stock Holdings in Cytokinetics, Incorporated $CYTKSeptember 14 at 4:12 AM | marketbeat.comBayforest Capital Ltd Raises Holdings in Cytokinetics, Incorporated $CYTKSeptember 13, 2025 | marketbeat.comCytokinetics (NASDAQ:CYTK) EVP Sells 2,000 SharesSeptember 12, 2025 | marketbeat.comCytokinetics (CYTK): Is the Current Market Valuation Overlooking the Company’s Long-Term Potential?September 11, 2025 | finance.yahoo.comCytokinetics (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 2,000 SharesSeptember 11, 2025 | insidertrades.comZimmer Partners LP Buys 44,132 Shares of Cytokinetics, Incorporated $CYTKSeptember 11, 2025 | marketbeat.comCytokinetics, Incorporated (NASDAQ:CYTK) Receives Average Recommendation of "Moderate Buy" from BrokeragesSeptember 10, 2025 | marketbeat.comCytokinetics, Incorporated (CYTK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 9, 2025 | seekingalpha.comAlliancebernstein L.P. Trims Stock Position in Cytokinetics, Incorporated $CYTKSeptember 9, 2025 | marketbeat.comCytokinetics, Incorporated (NASDAQ:CYTK) Receives Average Rating of "Moderate Buy" from AnalystsSeptember 9, 2025 | americanbankingnews.comPentwater Capital Management LP Sells 229,100 Shares of Cytokinetics, Incorporated $CYTKSeptember 8, 2025 | marketbeat.comAlyeska Investment Group L.P. Reduces Position in Cytokinetics, Incorporated $CYTKSeptember 8, 2025 | marketbeat.comGraham Capital Management L.P. Invests $643,000 in Cytokinetics, Incorporated $CYTKSeptember 8, 2025 | marketbeat.com52,321 Shares in Cytokinetics, Incorporated $CYTK Purchased by Cinctive Capital Management LPSeptember 7, 2025 | marketbeat.comCytokinetics (CYTK) Gets a Buy from BarclaysSeptember 6, 2025 | theglobeandmail.comCytokinetics (CYTK) Receives a Buy from Morgan StanleySeptember 6, 2025 | theglobeandmail.comEventide Asset Management LLC Increases Stock Holdings in Cytokinetics, Incorporated $CYTKSeptember 6, 2025 | marketbeat.comCutter Capital Management LP Takes Position in Cytokinetics, Incorporated $CYTKSeptember 6, 2025 | marketbeat.comBarclays Raises Cytokinetics (NASDAQ:CYTK) Price Target to $71.00September 5, 2025 | marketbeat.comCytokinetics (NASDAQ:CYTK) Price Target Raised to $80.00September 5, 2025 | marketbeat.comCytokinetics price target raised to $52 from $45 at BofASeptember 4, 2025 | msn.comCytokinetics (NASDAQ:CYTK) Director Edward Md Kaye Sells 6,756 SharesSeptember 4, 2025 | marketbeat.comCytokinetics (NASDAQ:CYTK) Shares Gap Up Following Analyst UpgradeSeptember 4, 2025 | marketbeat.comCytokinetics (NASDAQ:CYTK) Price Target Raised to $84.00September 4, 2025 | marketbeat.comStifel Nicolaus Boosts Cytokinetics (NASDAQ:CYTK) Price Target to $96.00September 4, 2025 | marketbeat.comTraders Buy Large Volume of Call Options on Cytokinetics (NASDAQ:CYTK)September 4, 2025 | marketbeat.comCytokinetics (NASDAQ:CYTK) Earns Market Outperform Rating from JMP SecuritiesSeptember 4, 2025 | marketbeat.comCytokinetics (NASDAQ:CYTK) Earns "Buy" Rating from Needham & Company LLCSeptember 4, 2025 | marketbeat.comCytokinetics, Incorporated $CYTK Shares Sold by ADAR1 Capital Management LLCSeptember 4, 2025 | marketbeat.comCytokinetics, Incorporated $CYTK Position Lessened by Redmile Group LLCSeptember 4, 2025 | marketbeat.comCytokinetics, Incorporated $CYTK Shares Acquired by Vestal Point Capital LPSeptember 4, 2025 | marketbeat.comCytokinetics (CYTK) Rockets 40.45% as Aficamten Results PromisingSeptember 4, 2025 | msn.comCytokinetics price target raised to $71 from $53 at BarclaysSeptember 3, 2025 | msn.comCytokinetics (NASDAQ:CYTK) Director Sells $337,800.00 in StockSeptember 3, 2025 | insidertrades.comCytokinetics, Incorporated (CYTK) Presents at Citi's Biopharma Back to School Conference - SlideshowSeptember 2, 2025 | seekingalpha.comCytokinetics stock soars after impressive heart drug dataSeptember 2, 2025 | za.investing.comBitcoin gains, Frontier upgraded, Cytokinetics trial resultsSeptember 2, 2025 | finance.yahoo.comCytokinetics, Incorporated (CYTK) Presents At Citi's Biopharma Back To School Conference TranscriptSeptember 2, 2025 | seekingalpha.comCytokinetics: Game-Changing Data Confirms Best-In-Class PotentialSeptember 2, 2025 | seekingalpha.comCytokinetics, Incorporated - Exploring The Changing Treatment Paradigm TranscriptSeptember 2, 2025 | seekingalpha.comCytokinetics Stock Jumps. The Biotech's Heart Drug Wows.September 2, 2025 | barrons.comParadigm Biocapital Advisors LP Takes $34.51 Million Position in Cytokinetics, Incorporated $CYTKSeptember 2, 2025 | marketbeat.com Get Cytokinetics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYTK Media Mentions By Week CYTK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYTK News Sentiment▼0.890.92▲Average Medical News Sentiment CYTK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYTK Articles This Week▼1711▲CYTK Articles Average Week Get the Latest News and Ratings for CYTK and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cytokinetics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BioNTech News Teva Pharmaceutical Industries News Genmab A/S News Summit Therapeutics News Dr. Reddy's Laboratories News Ascendis Pharma A/S News Viatris News QIAGEN News BridgeBio Pharma News Roivant Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYTK) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYTK Stock Alerts